Sci4Pharma (Strategic Competitive Intelligence for Pharmaceutical Companies) is a business consulting firm formed in 2023. It focuses on strategic competitive intelligence that aims to help pharma companies make better strategic business decisions. While simple competitive intelligence provides companies with information on what is going on, a more focused strategic competitive intelligence adds degrees of relevance and impact in the information to make it readily usable for the pharmaceutical companies in making better strategic business decisions.
Sci4Pharma provides strategic competitive intelligence to pharmaceutical companies for making better business decisions. Its core services include carrying out projects for Competitive Intelligence, Commercial Strategy, Disease Area Strategy, Opportunity Assessment and Portfolio Strategy.
Sci4Pharma is headed by Dr Hamid Hasan Faridi, MD (MBBS), MBA, who has more than 10 years of experience in the pharmaceutical space. He has worked in pharma consulting companies such as ZS, SmartAnalyst and WNS, and in pharma companies at senior positions (Senior Manager, Strategic Competitive Intelligence in Cipla, and Assistant Director, Corporate Development, in Engrail Therapeutics). Dr Hamid lead many competitive intelligence and strategy projects at Cipla and Engrail Therapeutics, and helped the leadership in making more accurate business decisions.